How to buy Quotient stock | $5.21

Quotient Limited is a diagnostics & research business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 420 staff and has a trailing 12-month revenue of around USD$41.6 million.

How to buy shares in Quotient

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Quotient. Find the stock by name or ticker symbol: QTNT. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Quotient reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$5.21, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Quotient, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Quotient. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Quotient share price

Use our graph to track the performance of QTNT stocks over time.

Quotient shares at a glance

• Key figures

Information last updated 2020-12-28.

Latest market close	USD$5.21
52-week range	USD$2.395 - USD$9.65
50-day moving average	USD$6.4791
200-day moving average	USD$6.3333
Wall St. target price	USD$12.67
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.731

Buy Quotient shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Quotient stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Quotient Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quotient price performance over time

Historical closes compared with the close of $5.21 from 2020-12-31

1 week (2021-01-07)	-6.63%
1 month (2020-12-16)	-25.25%
3 months (2020-10-16)	5.25%
6 months (2020-07-16)	-36.54%

1 year (2020-01-16)	-40.11%
2 years (2019-01-16)	-30.81%
3 years (2018-01-16)	24.34%
5 years (2016-01-15)	13.98

Quotient financials

Revenue TTM	USD$41.6 million
Gross profit TTM	USD$14.9 million
Return on assets TTM	-20.78%
Return on equity TTM	0%
Profit margin	-222.47%
Book value	$0.334
Market capitalisation	USD$553.6 million

TTM: trailing 12 months

Shorting Quotient shares

There are currently 4.9 million Quotient shares held short by investors – that's known as Quotient's "short interest". This figure is 1.5% down from 5.0 million last month.

There are a few different ways that this level of interest in shorting Quotient shares can be evaluated.

Quotient's "short interest ratio" (SIR)

Quotient's "short interest ratio" (SIR) is the quantity of Quotient shares currently shorted divided by the average quantity of Quotient shares traded daily (recently around 830242.80879865). Quotient's SIR currently stands at 5.91. In other words for every 100,000 Quotient shares traded daily on the market, roughly 5910 shares are currently held short.

However Quotient's short interest can also be evaluated against the total number of Quotient shares, or, against the total number of tradable Quotient shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quotient's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Quotient shares in existence, roughly 50 shares are currently held short) or 0.0571% of the tradable shares (for every 100,000 tradable Quotient shares, roughly 57 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Quotient.

Find out more about how you can short Quotient stock.

Quotient share dividends

We're not expecting Quotient to pay a dividend over the next 12 months.

Quotient share price volatility

Over the last 12 months, Quotient's shares have ranged in value from as little as $2.395 up to $9.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.6142. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Quotient overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Frequently asked questions

• What percentage of Quotient is owned by insiders or institutions?

  Currently 1.812% of Quotient shares are held by insiders and 91.662% by institutions.

• How many people work for Quotient?

  Latest data suggests 420 work at Quotient.

• When does the fiscal year end for Quotient?

  Quotient's fiscal year ends in March.

• Where is Quotient based?

  Quotient's address is: B1, Business Park Terre Bonne, Eysins, Switzerland, 1262

• What is Quotient's ISIN number?

  Quotient's international securities identification number is: JE00BLG2ZQ72

• What is Quotient's CUSIP number?

  Quotient's Committee on Uniform Securities Identification Procedures number is: G73268107